bpc 157 effectiveness clinical studies BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded What is BPC-157 and How
Description
Medication Medication (dose/kg b.w.) (pentadecapeptide BPC 157 (10 g, 10 ng), L-NAME 5 mg, L-arginine 100 mg given alone and/or together, while control received an equivolume of saline (5 ml)) was given intraperitoneally immediately after ethanol application

Experienced: Standard protocol at 1-2mg daily

These different amino acid substitutions exert distinct impact on the downstream mitogen-activated protein kinase (MAPK) signalling pathway, involving PI3K/AKT, mitogen-activated protein kinase kinase (MEKK) and RAS-like (RAL) GTPases

These revised criteria for diagnosing Alzheimer's and identifying where it is on the Alzheimer's disease continuum (called staging) were published in 2024
